Ravi Chari
- Oncology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 0.2%
- Molecular Biology top 2%
- Organic Chemistry top 2%
- Biomedical Engineering top 5%
- Co-authors
- Wayne C. WiddisonJohn M. LambertMichael L. MillerBeverly A. TeicherRobert J. LutzVictor S. GoldmacherWalter A. BlättlerYelena Kovtun
- Topics
- HER2/EGFR in Cancer Research (44 papers)Monoclonal and Polyclonal Antibodies Research (44 papers)Radiopharmaceutical Chemistry and Applications (10 papers)
- Journals
- Journal of the American Chemical SocietyAngewandte Chemie International EditionJournal of Clinical Oncology
- Partner nations
- United StatesGreeceCroatia
In The Last Decade
Ravi Chari
73 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 3.7k
- Radiology, Nuclear Medicine and Imaging 3.4k
- Molecular Biology 2.6k
- Organic Chemistry 808
- Biomedical Engineering 532
Countries citing papers authored by Ravi Chari
This map shows the geographic impact of Ravi Chari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Chari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Chari more than expected).
Fields of papers citing papers by Ravi Chari
This network shows the impact of papers produced by Ravi Chari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Chari. The network helps show where Ravi Chari may publish in the future.
Co-authorship network of co-authors of Ravi Chari
This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Chari. A scholar is included among the top collaborators of Ravi Chari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Chari. Ravi Chari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 29 | |
| 3 | 129 | |
| 4 | 65 | |
| 5 | 48 | |
| 6 | Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapybreakdown → | 759 |
| 7 | 150 | |
| 8 | 48 | |
| 9 | 169 | |
| 10 | 194 | |
| 11 | 134 | |
| 12 | Evaluation of the cytotoxic potencies of the major maytansinoid metabolites of antibody maytansinoid conjugates detected in vitro and in preclinical mouse models | 4 |
| 13 | Maytansine derivatives and metabolites of antibody-maytansinoid conjugates inhibit microtubule polymerization and strongly suppress microtubule dynamics | 1 |
| 14 | Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugatebreakdown → | 1259 |
| 15 | Linker selection in antibody-maytansinoid conjugates impacts bystander killing in mouse xenograft models | 1 |
| 16 | HuC242-DM4, an antibody-maytansinoid conjugate with superior preclinical activity in human CanAg-positive tumor xenograft models in SCID mice | 5 |
| 17 | 11 | |
| 18 | 15 | |
| 19 | 18 | |
| 20 | 76 |
About Ravi Chari
Ravi Chari is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry, having authored 76 papers that have together received 6.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (44 papers), Monoclonal and Polyclonal Antibodies Research (44 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.4k citations), Oncology (3.7k citations) and Molecular Biology (2.6k citations). Ravi Chari has collaborated with scholars based in United States, Greece and Croatia. Frequent co-authors include Wayne C. Widdison, John M. Lambert, Michael L. Miller, Beverly A. Teicher, Robert J. Lutz, Victor S. Goldmacher, Walter A. Blättler, Yelena Kovtun, Sharon Wilhelm and Elaine Mai. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.